FDA
-
-
-
-
-
-
-
Arch Therapeutics Provides AC5® Commercialization Update
-
-
-
-
-
-
-
Arch Therapeutics Announces Intent to Uplist from OTC to a National Exchange
-
-
-
-
-
-
-
Arch Therapeutics, Inc. (ARTH) Reports 510(k) Submission to U.S. FDA for AC5 Topical Gel
-
-
-
-
-
-
-
Arch Therapeutics Provides Update on 510(k)
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

